NCT06180200View on ClinicalTrials.gov

Study of the in Vivo Expression of MU Opioid Receptors Using PET and the Selective Tracer [C-11] Carfentanil in Normal Weight and Obese Subjects

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

October 22, 2004

Primary Completion Date

December 1, 2007

Study Completion Date

December 1, 2007

Conditions
Nuclear Medicine
Interventions
DIAGNOSTIC_TEST

PET for the analysis of mu opioid receptor expression.

PET for the analysis of the expression of mu opioid receptors and to directly measure the distribution of the receptors and enzyme reuptake sites at the brain level.

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT06180200 - Study of the in Vivo Expression of MU Opioid Receptors Using PET and the Selective Tracer [C-11] Carfentanil in Normal Weight and Obese Subjects | Biotech Hunter | Biotech Hunter